Centricity Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50
Closed -$629 431
2025
Q1
$716 Sell
50
-28
-36% -$437 ﹤0.01% 434
2024
Q4
$1.24K Buy
+78
New +$1.54K ﹤0.01% 434

Other funds holding AVNS

Centricity Wealth Management's AVNS Position: Q2 2025 in Review

Centricity Wealth Management sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 50 shares — an estimated $629 sold.

Centricity Wealth Management first reported a position in AVNS in Q4 2024 and held it in 2 quarters. The position peaked at $1.24K in Q4 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Centricity Wealth Management reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Centricity Wealth Management sold 50 Avanos Medical shares in Q2 2025, an estimated $629.
  • Centricity Wealth Management first reported a position in Avanos Medical in Q4 2024 and held it in 2 quarters.
  • Centricity Wealth Management's Avanos Medical position peaked at $1.24K in Q4 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.